Lung cancer screening in Lebanon: Joint statement from the Lebanese Pulmonary Society and the Lebanese Society of Medical Oncology

Lung cancer is the leading cause of mortality worldwide. The 5‑year survival rate patients ~15%, since majority present with disease at an advanced stage. resulting burden from this entails solid efforts towards early detection and smoking cessation. In Lebanon, triad high incidence lung cancer, extensive tobacco consumption delayed diagnosis calls for urgent actions. Furthermore, screening a low‑dose computed tomography (CT) scan allows reduces rates, as documented in several randomized trials meta‑analyses recommended by international relevant societies. A panel Lebanese experts, members Society Medical Oncology Pulmonary Society, have convened discussed all aspects challenges related to implementation Lebanon. Accordingly, national guidelines were proposed joint statement, which defines particular high‑risk population that would most benefit screening. Pillars success involve solid, evidence‑based program, efficient cessation programs proper referral follow‑up. parallel, quality logistical basic requirements must be optimized well‑equipped centers, trained personnel expert radiologists; addition promoting awareness, adherence sustainability. Physicians need ensure accurate risk stratification referrals different specialties. Awareness should also raised general on safety benefits CT, encourage via dedicated programs. country where economic situation challenging, third‑party payers are resistant cover initiatives, support Ministry Public Health warranted, along cost‑effectiveness analysis uncover elevated cost treating stage cancer.